Castleark Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Castleark Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-92,031	Closed	-$12.5M	–	381
2020 Q3	$12.5M	Buy	92,031 +21,005	+30%	+$2.23M	0.49%	49
2020 Q2	$6.86M	Sell	71,026 -20,580	-22%	-$1.72M	0.3%	100
2020 Q1	$4.29M	Sell	91,606 -24,305	-21%	-$1.56M	0.25%	113
2019 Q4	$8.45M	Sell	115,911 -17,264	-13%	-$1.05M	0.34%	100
2019 Q3	$6.95M	Buy	+133,175	New	+$7.08M	0.28%	125
2019 Q1	–	Sell	-22,540	Closed	-$1.1M	–	427
2018 Q4	$1.1M	Buy	+22,540	New	+$1.24M	0.05%	259

Castleark Management's MYOK Position: Q4 2020 in Review

Castleark Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 92,031 shares — an estimated $12.5M sold.

Castleark Management first reported a position in MYOK in Q4 2018 and held it in 6 quarters. The position peaked at $12.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Castleark Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Castleark Management sold 92,031 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $12.5M.
Castleark Management first reported a position in MyoKardia, Inc. Common Stock in Q4 2018 and held it in 6 quarters.
Castleark Management's MyoKardia, Inc. Common Stock position peaked at $12.5M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Castleark Management's 13F filing for Q4 2020, filed 17 Feb 2021.